바이오시밀러 후보물질

Biotherapeutic Pipelines
Product Specifications Indication Research Preclinical Clinical
Phase I
Clinical
Phase II
Clinical
Phase III
RBS-001 Biosimilar nAMD
RBB-002 Biobetter nAMD DME
RBS-003 Biosimilar NSCLC